Oxidative stress correlates with headache symptoms in Fibromyalgia: Coenzyme Q 10 effect on clinical improvement

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Cordero, Mario D ^a,b   Cano García, Francisco Javier ^c   Alcocer Gómez, Elísabet ^c   de Miguel, Manuel ^b   Sánchez Alcázar, José Antonio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTEROL; CREATININE; MALONALDEHYDE; TRIACYLGLYCEROL; UBIDECARENONE; URIC ACID; DRUG DERIVATIVE; UBIQUINONE; VITAMIN;

ADULT; ARTICLE; BIOENERGY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE DURATION; DISEASE SEVERITY; FIBROMYALGIA; FIBROMYLAGIA IMPACT QUESTIONNAIRE; HEADACHE; HEADACHE IMPACT TEST; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; QUESTIONNAIRE; RATING SCALE; SYMPTOMATOLOGY; VISUAL ANALOG SCALE; BLOOD; DRUG EFFECT; FEMALE; METABOLISM; MIDDLE AGED; PAIN ASSESSMENT;

ADENOSINE TRIPHOSPHATE; ADULT; CATALASE; FEMALE; FIBROMYALGIA; HEADACHE; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; OXIDATIVE STRESS; PAIN MEASUREMENT; UBIQUINONE; VITAMINS;

EID: 84859841144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035677     Document Type: Article

References (42)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-72.
2. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, et al. (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58: 26-35.
3. Peres MFP, Young WB, Kaup AO, Zukerman E, Silberstein SD, (2001) Fibromyalgia is common in patients with transformed migraine. Neurology 57: 1326-8.
4. Marcus DA, Bernstein C, Rudy TE, (2005) Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol 24: 595-601.
5. Centonze V, Bassi A, Cassiano A, Munno I, Dalfino L, et al. (2004) Migraine, daily chronic headache and fibromyalgia in the same patient: an evolutive 'continuum' of non organic chronic pain? About 100 clinical cases. Neurol Sci 25: S291-S292.
6. Cordero MD, Alcocer-Gómez E, Cano-García FJ, De Miguel M, Carrión AM, et al. (2011) Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 6: e26915.
7. Gupta R, Pathak R, Bhatia MS, Banerjee BD, (2009) Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group. Ann Indian Acad Neurol 12: 167-72.
8. Cordero MD, Moreno-Fernandez AM, deMiguel M, Bonal P, Campa F, et al. (2009) Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 42: 732-5.
9. Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, et al. (2007) Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47: 73-80.
10. Beers RF Jr, Sizer IW, (1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195: 133-140.
11. Turunen M, Olsson J, Dallner G, (2004) Metabolism and function of coenzyme Q. Biochim Biophys Acta 1660: 171-199.
12. Samorì B, Lenaz G, Battino M, Marconi G, Domini I, (1992) On coenzyme Q orientation in membranes: a linear dichroism study of ubiquinones in a model bilayer. J Membr Biol 128: 193-203.
13. Rauchová H, Battino M, Fato R, Lenaz G, Drahota Z, (1992) Coenzyme Q-pool function in glycerol-3-phosphate oxidation in hamster brown adipose tissue mitochondria. J Bioenerg Biomembr 24: 235-41.
14. Battino M, Fato R, Parenti-Castelli G, Lenaz G, (1990) Coenzyme Q can control the efficiency of oxidative phosphorylation. Int J Tissue React 12: 137-44.
15. Lenaz G, Battino M, Castelluccio C, Fato R, Cavazzoni M, et al. (1990) Studies on the role of ubiquinone in the control of the mitochondrial respiratory chain. Free Radic Res Commun 8: 317-27.
16. Littarru GP, Tiano L, (2010) Clinical aspects of coenzyme Q10: An update. Nutrition 26: 250-4.
17. Lodi R, Rinaldi R, Gaddi A, Iotti S, D'Alessandro R, et al. (1997) Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia. J Neurol Neurosurg Psychiatry 62: 574-80.
18. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, et al. (2009) Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 30: 462-9.
19. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, et al. (2009) Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett 30: 470-6.
20. Rodríguez-Hernández A, Cordero MD, Salviati L, Artuch R, Pineda M, et al. (2009) Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 5: 19-32.
21. Cotán D, Cordero MD, Garrido-Maraver J, Oropesa-Ávila M, Rodríguez-Hernández A, et al. (2011) Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J 25: 2669-87.
22. Andersen JK, (2004) Oxidative stress in neurodegeneration: cause or consequence? Nature Reviews Neuroscience 5: S18-S25.
23. Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbiçer H, (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126: 92-7.
24. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A, (2003) Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 23: 39-42.
25. Keller JN, Mattson MP, (1998) Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 9: 105-16.
26. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, et al. (2004) A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 309: 869-78.
27. Tomasetti M, Alleva R, Borghi B, Collins AR, (2001) In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J 15: 1425-7.
28. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME, (2006) Mitochondrial dysfunction and migraine: Evidence and hypotheses. Cephalalgia 26: 361-372.
29. Moskowitz MA, (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43: S16-S20.
30. Staud R, (2002): Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 4: 299-305.
31. Gur A, Oktayoglu P, (2008) Status of immune mediators in fibromyalgia. Curr Pain Headache Rep 12: 175-181.
32. Lucas HJ, Brauch CM, Settas L, Theoharides TC, (2006) Fibromyalgia-new concepts of pathogenesis and treatment. Int J Immunopathol Pharmacol 2006 19: 5-10.
33. Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, et al. (2003) Detection of interleukin lbeta (IL-lbeta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 30: 146-150.
34. Uzar E, Evliyaoglu O, Yucel Y, Ugur Cevik M, Acar A, et al. (2011) Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 2011 15 (10): 1111-6.
35. Vanmolkot FH, de Hoon JN, (2007) Increased C-reactive protein in young adult patients with migraine. Cephalalgia 27: 843-846.
36. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, et al. (1997) Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40: 1571-1579.
37. Bisaglia M, Venezia V, Piccioli P, Stanzione S, Porcile C, et al. (2002) Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid-peptides induced oxidative stress and reduces NF-κB activation. Neurochem Int 41: 43-54.
38. Maharaj H, Maharaj DS, Daya S, (2006) Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity. Metab Brain Dis 21: 189-199.
39. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F, (2008) Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 37: 353-65.
40. Sarzi-Puttini P, Atzeni F, Salaffi F, Cazzola M, Benucci M, et al. (2011) Multidisciplinary approach to fibromyalgia: what is the teaching? Best Pract Res Clin Rheumatol 25: 311-9.
41. Dupic L, Huet O, Duranteau J, (2011) Coenzyme Q10 deficiency in septic shock patients. Crit Care 15: 194.
42. Kunitomo M, Yamaguchi Y, Kagota S, Otsubo K, (2008) Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci 107: 128-37.